⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASND News
Ascendis Pharma A/S American Depositary Shares
Battery Cathode Materials Market Size, Share, Trends, and Industry Analysis - Global Forecast 2026-2036 | US$103.66 Billion Opportunity Fueled by EVs, LFP, Sodium-Ion, and Energy Storage
globenewswire.com
BWEN
RDWR
ASND
TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years
globenewswire.com
ASND
StaffGarden Launches Evidence-Based RN Competencies, Built on Decades of Versant Research, to Advance Workforce Readiness
globenewswire.com
ASND
Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children
globenewswire.com
ASND
Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026
globenewswire.com
ASND
Ascendis Announces Planned $400 Million Share Repurchase Program
globenewswire.com
ASND
Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
globenewswire.com
ASND
First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026
globenewswire.com
ASND
Ascendis Pharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
globenewswire.com
ASND
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE 2026
globenewswire.com
ASND